[go: up one dir, main page]

MA31541B1 - Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine - Google Patents

Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine

Info

Publication number
MA31541B1
MA31541B1 MA32551A MA32551A MA31541B1 MA 31541 B1 MA31541 B1 MA 31541B1 MA 32551 A MA32551 A MA 32551A MA 32551 A MA32551 A MA 32551A MA 31541 B1 MA31541 B1 MA 31541B1
Authority
MA
Morocco
Prior art keywords
pharmaceutical composition
phenorolpenes
soluble salt
stable pharmaceutical
vinorelbine
Prior art date
Application number
MA32551A
Other languages
Arabic (ar)
English (en)
Inventor
Bruno Paillard
Jean-Louis Avan
JOëL BOUGARET
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MA31541B1 publication Critical patent/MA31541B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention porte sur une composition pharmaceutique stable comprenant un sel de vinorelbine soluble dans l'eau et au moins un diluant et un lubrifiant, caractérisé par le fait qu'il apparaît sous une forme solide destiné à une administration orale. Le sel de vinorelbine soluble dans l'eau est avantageusement le ditartrate de vinorelbine. La composition pharmaceutique apparaît de manière avantageuse sous forme de capsule de gélatine ou de comprimé.
MA32551A 2007-07-11 2010-01-25 Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine MA31541B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0756425A FR2918567B1 (fr) 2007-07-11 2007-07-11 Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
PCT/EP2008/058896 WO2009007389A1 (fr) 2007-07-11 2008-07-09 Composition pharmaceutique stable d'un sel de vinorelbine soluble dans l'eau

Publications (1)

Publication Number Publication Date
MA31541B1 true MA31541B1 (fr) 2010-07-01

Family

ID=38846787

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32551A MA31541B1 (fr) 2007-07-11 2010-01-25 Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine

Country Status (22)

Country Link
US (1) US20100196465A1 (fr)
EP (1) EP2175855B1 (fr)
JP (1) JP5774308B2 (fr)
KR (1) KR20100045439A (fr)
CN (1) CN101730534A (fr)
AR (1) AR067498A1 (fr)
AU (1) AU2008274224A1 (fr)
BR (1) BRPI0814224A2 (fr)
CA (1) CA2695040A1 (fr)
DK (1) DK2175855T3 (fr)
ES (1) ES2733113T3 (fr)
FR (1) FR2918567B1 (fr)
HU (1) HUE044165T2 (fr)
MA (1) MA31541B1 (fr)
NZ (1) NZ583039A (fr)
PL (1) PL2175855T3 (fr)
RU (1) RU2476208C2 (fr)
TN (1) TN2010000012A1 (fr)
TR (1) TR201909405T4 (fr)
TW (1) TW200914017A (fr)
WO (1) WO2009007389A1 (fr)
ZA (1) ZA201000337B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105267179B (zh) * 2014-07-08 2020-04-03 东曜药业有限公司 包含水溶性长春瑞滨盐的稳定的固体药物组合物及其制备方法
JP2019508436A (ja) 2016-03-09 2019-03-28 シンバイアス ファーマ アー・ゲー ビノレルビンモノタルトラートおよびその薬学的使用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879541A (en) * 1970-03-03 1975-04-22 Bayer Ag Antihyperglycemic methods and compositions
US4551177A (en) * 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
CA2327285C (fr) * 1998-05-15 2005-06-14 Warner-Lambert Company Preparations pharmaceutiques stabilisees de derives d'acide gamma-aminobutyrique et procede de fabrication associe
US6242003B1 (en) * 2000-04-13 2001-06-05 Novartis Ag Organic compounds
CZ289261B6 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
PL362687A1 (en) * 2001-01-12 2004-11-02 Sun Pharmaceutical Industries Limited Spaced drug delivery system
WO2003090742A1 (fr) * 2002-04-26 2003-11-06 F. Hoffmann-La Roche Ag Composition pharmaceutique comportant un inhibiteur des lipases et du glucomannan
JP2003321349A (ja) * 2002-05-08 2003-11-11 Capsugel Japan Inc イカスミ色素含有インクによる硬質カプセルへの印刷
EP1530459B1 (fr) * 2002-05-31 2010-03-31 R.P. Scherer Technologies, LLC Composition pharmaceutique orale pour capsules souples contenant de la vinorelbine et procede de traitement correspondant
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
US20030138430A1 (en) * 2002-09-20 2003-07-24 Stimmel Julie Beth Pharmaceutical comprising an agent that blocks the cell cycle and an antibody
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
RU2412687C2 (ru) * 2004-12-30 2011-02-27 Пьер Фабр Медикаман Стабильная твердая дисперсия производного винка-алкалоида и способ ее получения

Also Published As

Publication number Publication date
BRPI0814224A2 (pt) 2015-01-06
US20100196465A1 (en) 2010-08-05
KR20100045439A (ko) 2010-05-03
AR067498A1 (es) 2009-10-14
TN2010000012A1 (en) 2011-09-26
FR2918567B1 (fr) 2012-08-03
ZA201000337B (en) 2010-09-29
EP2175855B1 (fr) 2019-04-10
PL2175855T3 (pl) 2019-10-31
JP5774308B2 (ja) 2015-09-09
NZ583039A (en) 2012-06-29
HUE044165T2 (hu) 2019-10-28
CN101730534A (zh) 2010-06-09
TW200914017A (en) 2009-04-01
FR2918567A1 (fr) 2009-01-16
JP2010533140A (ja) 2010-10-21
EP2175855A1 (fr) 2010-04-21
TR201909405T4 (tr) 2019-07-22
CA2695040A1 (fr) 2009-01-15
RU2010103935A (ru) 2011-08-20
ES2733113T3 (es) 2019-11-27
RU2476208C2 (ru) 2013-02-27
DK2175855T3 (da) 2019-07-01
AU2008274224A1 (en) 2009-01-15
WO2009007389A1 (fr) 2009-01-15

Similar Documents

Publication Publication Date Title
TNSN01123A1 (fr) Formes posologiques nouvelles a liberation controlee
EP1676559A3 (fr) Article cosmétique ou dermatologique comportant un support soluble dans l'eau
WO2005072079A3 (fr) Enrobage de medicaments a charge medicamenteuse elevee et procedes de fabrication
WO2001076561A3 (fr) Compositions pharmaceutiques
MY135119A (en) Stabilized oral suspension formulation
WO2007067593A3 (fr) Formulations d'inhibiteur de cetp
BRPI0408065A (pt) pó impregnado, processo de fabricação do mesmo e sua utilização
WO2006081363A3 (fr) Formulations orales pour l'administration de butanes catecholiques comprenant des composes ndga
WO2005004917A3 (fr) Composition pharmaceutique destinee a renforcer la solubilite de medicaments hydrophobes
WO2007100382A3 (fr) Préparations de gallium administrables per os et leurs méthodes d'utilisation
FR2909284B1 (fr) Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
ES2185584T3 (es) Procedimiento para estabilizar preparaciones de polivinilpirrolidona.
EE200100054A (et) Pantoprasoolmagneesiumdihüdraat, seda sisaldav ravim ja selle kasutamine
TR200401906T4 (tr) Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır.
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
MA27904A1 (fr) Forme dosifiee orale de mesylate de saquinavir
EP3905898C0 (fr) Formulation de nicotine liquide comprenant des solvants miscibles dans l'eau
SE0000774D0 (sv) New formulation
MA31541B1 (fr) Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
BR0209155A (pt) Tablete farmacêutico tendo um teor de api elevado
BR0009334A (pt) Excipiente na forma de pó para o uso emapresentações farmacêuticas sólidas, e, processopara produzir o mesmo
MA32045B1 (fr) Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine
BRPI0513051A (pt) combinação de inibidores de transcriptase reversa e de protease anti-hiv
DK1102594T3 (da) Anvendelse af natriumchlorid til nedsættelse af den gastrointestinale toxicitet af derivater af camptothecin